Household Transmission of Influenza A Viruses in 2021-2022.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
14 02 2023
Historique:
pubmed: 27 1 2023
medline: 17 2 2023
entrez: 26 1 2023
Statut: ppublish

Résumé

Influenza virus infections declined globally during the COVID-19 pandemic. Loss of natural immunity from lower rates of influenza infection and documented antigenic changes in circulating viruses may have resulted in increased susceptibility to influenza virus infection during the 2021-2022 influenza season. To compare the risk of influenza virus infection among household contacts of patients with influenza during the 2021-2022 influenza season with risk of influenza virus infection among household contacts during influenza seasons before the COVID-19 pandemic in the US. This prospective study of influenza transmission enrolled households in 2 states before the COVID-19 pandemic (2017-2020) and in 4 US states during the 2021-2022 influenza season. Primary cases were individuals with the earliest laboratory-confirmed influenza A(H3N2) virus infection in a household. Household contacts were people living with the primary cases who self-collected nasal swabs daily for influenza molecular testing and completed symptom diaries daily for 5 to 10 days after enrollment. Household contacts living with a primary case. Relative risk of laboratory-confirmed influenza A(H3N2) virus infection in household contacts during the 2021-2022 season compared with prepandemic seasons. Risk estimates were adjusted for age, vaccination status, frequency of interaction with the primary case, and household density. Subgroup analyses by age, vaccination status, and frequency of interaction with the primary case were also conducted. During the prepandemic seasons, 152 primary cases (median age, 13 years; 3.9% Black; 52.0% female) and 353 household contacts (median age, 33 years; 2.8% Black; 54.1% female) were included and during the 2021-2022 influenza season, 84 primary cases (median age, 10 years; 13.1% Black; 52.4% female) and 186 household contacts (median age, 28.5 years; 14.0% Black; 63.4% female) were included in the analysis. During the prepandemic influenza seasons, 20.1% (71/353) of household contacts were infected with influenza A(H3N2) viruses compared with 50.0% (93/186) of household contacts in 2021-2022. The adjusted relative risk of A(H3N2) virus infection in 2021-2022 was 2.31 (95% CI, 1.86-2.86) compared with prepandemic seasons. Among cohorts in 5 US states, there was a significantly increased risk of household transmission of influenza A(H3N2) in 2021-2022 compared with prepandemic seasons. Additional research is needed to understand reasons for this association.

Identifiants

pubmed: 36701144
pii: 2800976
doi: 10.1001/jama.2023.0064
pmc: PMC9880862
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

482-489

Subventions

Organisme : NIAID NIH HHS
ID : K24 AI148459
Pays : United States
Organisme : NCIRD CDC HHS
ID : U01 IP001083
Pays : United States
Organisme : NCIRD CDC HHS
ID : U01 IP001078
Pays : United States

Auteurs

Melissa A Rolfes (MA)

Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.

H Keipp Talbot (HK)

Vanderbilt University Medical Center, Nashville, Tennessee.

Huong Q McLean (HQ)

Marshfield Clinic Research Institute, Marshfield, Wisconsin.

Melissa S Stockwell (MS)

Columbia University, New York City, New York.

Katherine D Ellingson (KD)

University of Arizona, Tucson.

Karen Lutrick (K)

University of Arizona, Tucson.

Natalie M Bowman (NM)

University of North Carolina at Chapel Hill.

Emily E Bendall (EE)

University of Michigan, Ann Arbor.

Ayla Bullock (A)

University of North Carolina at Chapel Hill.

James D Chappell (JD)

Vanderbilt University Medical Center, Nashville, Tennessee.

Jessica E Deyoe (JE)

Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.

Julie Gilbert (J)

University of Michigan, Ann Arbor.

Natasha B Halasa (NB)

Vanderbilt University Medical Center, Nashville, Tennessee.

Kimberly E Hart (KE)

Vanderbilt University Medical Center, Nashville, Tennessee.

Sheroi Johnson (S)

Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.

Ahra Kim (A)

Vanderbilt University Medical Center, Nashville, Tennessee.

Adam S Lauring (AS)

University of Michigan, Ann Arbor.

Jessica T Lin (JT)

University of North Carolina at Chapel Hill.

Christopher J Lindsell (CJ)

Vanderbilt University Medical Center, Nashville, Tennessee.

Son H McLaren (SH)

Columbia University, New York City, New York.

Jennifer K Meece (JK)

Marshfield Clinic Research Institute, Marshfield, Wisconsin.

Alexandra M Mellis (AM)

Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.

Miriana Moreno Zivanovich (M)

University of North Carolina at Chapel Hill.

Constance E Ogokeh (CE)

Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.

Michelle Rodriguez (M)

Columbia University, New York City, New York.

Ellen Sano (E)

Columbia University, New York City, New York.

Raul A Silverio Francisco (RA)

Columbia University, New York City, New York.

Jonathan E Schmitz (JE)

Vanderbilt University Medical Center, Nashville, Tennessee.

Celibell Y Vargas (CY)

Columbia University, New York City, New York.

Amy Yang (A)

University of North Carolina at Chapel Hill.

Yuwei Zhu (Y)

Vanderbilt University Medical Center, Nashville, Tennessee.

Edward A Belongia (EA)

Marshfield Clinic Research Institute, Marshfield, Wisconsin.

Carrie Reed (C)

Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.

Carlos G Grijalva (CG)

Vanderbilt University Medical Center, Nashville, Tennessee.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH